[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:progressive-supranuclear-palsy":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":140,"states":141},"Progressive Supranuclear Palsy",21,17,[8,16,22,27,33,40,46,52,58,65,71,77,83,89,95,101,107,113,120,126,133],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07498426","A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy",[12],"Phase 3","RECRUITING","2026-08-26T02:17:05.172421Z","2026-05-13T02:55:06.710793Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04468932","Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy",[],"2026-08-26T02:15:11.740957Z","2026-05-05T02:43:28.301439Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":20,"content_modified":26},"NCT02795052","Neurologic Stem Cell Treatment Study",[],"2026-04-29T02:57:57.086071Z",{"nct_id":28,"title":29,"phases":30,"status":13,"updated_at":31,"content_modified":32},"NCT02605785","A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy",[],"2026-08-26T02:18:57.189473Z","2026-05-05T02:43:27.823519Z",{"nct_id":34,"title":35,"phases":36,"status":13,"updated_at":38,"content_modified":39},"NCT06303921","Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503",[37],"Early Phase 1","2026-08-26T02:18:11.042248Z","2026-05-05T02:43:29.498259Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT06032026","Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15",[37],"2026-08-26T02:17:06.985283Z","2026-05-05T02:43:29.328908Z",{"nct_id":47,"title":48,"phases":49,"status":13,"updated_at":14,"content_modified":51},"NCT07020026","Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease",[50],"Phase 2","2026-05-05T02:43:27.588819Z",{"nct_id":53,"title":54,"phases":55,"status":13,"updated_at":56,"content_modified":57},"NCT06083467","CW2IP2: Imaging and Diagnostic Assessments",[],"2026-08-26T02:17:23.750999Z","2026-05-05T02:43:27.262275Z",{"nct_id":59,"title":60,"phases":61,"status":13,"updated_at":63,"content_modified":64},"NCT03143374","PET Tau - Neurodegenerative Disease Imaging",[62],"Phase 2\u002FPhase 3","2026-08-26T02:16:03.788292Z","2026-05-05T02:43:28.343973Z",{"nct_id":66,"title":67,"phases":68,"status":13,"updated_at":69,"content_modified":70},"NCT06932809","Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A",[37],"2026-08-26T02:16:26.411851Z","2026-05-05T02:43:27.942188Z",{"nct_id":72,"title":73,"phases":74,"status":13,"updated_at":75,"content_modified":76},"NCT06647641","The CurePSP Genetics Program",[],"2026-08-26T02:16:21.385056Z","2026-05-13T02:55:06.558839Z",{"nct_id":78,"title":79,"phases":80,"status":13,"updated_at":81,"content_modified":82},"NCT03872102","Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging",[],"2026-08-26T02:15:52.238965Z","2026-05-13T02:55:06.179692Z",{"nct_id":84,"title":85,"phases":86,"status":13,"updated_at":87,"content_modified":88},"NCT06203106","NYSCF Scientific Discovery Biobank",[],"2026-08-26T02:15:57.572488Z","2026-05-13T02:55:06.425562Z",{"nct_id":90,"title":91,"phases":92,"status":13,"updated_at":93,"content_modified":94},"NCT04715399","UPenn Observational Research Repository on Neurodegenerative Disease",[],"2026-08-26T02:18:00.873391Z","2026-05-13T02:55:06.266233Z",{"nct_id":96,"title":97,"phases":98,"status":13,"updated_at":99,"content_modified":100},"NCT04363684","ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)",[],"2026-08-26T02:19:27.519777Z","2026-05-13T02:55:06.249799Z",{"nct_id":102,"title":103,"phases":104,"status":13,"updated_at":105,"content_modified":106},"NCT03225144","Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia",[],"2026-08-26T02:19:31.671303Z","2026-05-13T02:55:06.119817Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT02194816","Modifiable Variables in Parkinsonism (MVP)",[],"2026-08-26T02:17:05.997056Z","2026-05-13T02:55:06.083137Z",{"nct_id":114,"title":115,"phases":116,"status":117,"updated_at":118,"content_modified":119},"NCT04753320","Remote Monitoring in Progressive Supranuclear Palsy (PSP)",[],"NOT_YET_RECRUITING","2026-08-26T02:15:20.225313Z","2026-07-24T01:27:14.900280Z",{"nct_id":121,"title":122,"phases":123,"status":117,"updated_at":124,"content_modified":125},"NCT07240805","Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies",[],"2026-08-26T02:15:42.447052Z","2026-05-13T02:55:06.680076Z",{"nct_id":127,"title":128,"phases":129,"status":130,"updated_at":131,"content_modified":132},"NCT04680130","Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:56.561131Z","2026-07-05T18:42:10.712485Z",{"nct_id":134,"title":135,"phases":136,"status":137,"updated_at":138,"content_modified":139},"NCT02994719","Gait Analysis in Neurological Disease",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:52:12.406209Z","2026-05-13T02:55:06.105137Z",[],[142,146,150,154,157,161,164],{"state":143,"count":144,"slug":145},"Pennsylvania",7,"pennsylvania",{"state":147,"count":148,"slug":149},"Massachusetts",5,"massachusetts",{"state":151,"count":152,"slug":153},"Maryland",4,"maryland",{"state":155,"count":152,"slug":156},"Minnesota","minnesota",{"state":158,"count":159,"slug":160},"California",3,"california",{"state":162,"count":159,"slug":163},"Connecticut","connecticut",{"state":165,"count":159,"slug":166},"Florida","florida"]